4 ‘Strong Buy’/‘Buy’ Biotech Stocks
The author of today’s article notes that, while the “upside in biotech sector has been led by positive developments at small companies, primarily the ones… Read More »4 ‘Strong Buy’/‘Buy’ Biotech Stocks
Investing and Market Analysis
3 Top Stock Picks From The Outperforming Biotech Sector
“With the number of new drugs and biologics going up day by day, there has never been a better time to invest in biotech stocks,”… Read More »3 Top Stock Picks From The Outperforming Biotech Sector
Newer Biotech Issues To Watch
“With companies like Pfizer (NYSE:PFE) giving possible hope for an end of year vaccine and a recent gap up in IBB (Nasdaq Biotechnology ETF), now… Read More »Newer Biotech Issues To Watch
The Investment Thesis For Biotech (And Especially Biopharma)
Despite biotech’s outperformance year-to-date, the authors of today’s article still see the industry as attractive – and they outline three key strategic themes driving their… Read More »The Investment Thesis For Biotech (And Especially Biopharma)
This Buy-Rated Biotech With An Effective Alzheimer’s Drug Has Upside Potential Of Over 100%
After an initial analysis of clinical data back in May failed to demonstrate a statistically significant impact on the biomarkers associated with the disease, a… Read More »This Buy-Rated Biotech With An Effective Alzheimer’s Drug Has Upside Potential Of Over 100%
What Does “Merger Monday” Mean For Biotech?
“I believe that with the evidence of yesterday’s mergers, specifically the astoundingly well-priced purchase of Immunomedics (IMMU) by Gilead, that this is an area that… Read More »What Does “Merger Monday” Mean For Biotech?
Revisiting The Most Bought OTC Stock By Insiders In The Past Month
The company highlighted in today’s article – a direct-to-consumer telemedicine and wellness company – is the most bought OTC stock by insiders in the past… Read More »Revisiting The Most Bought OTC Stock By Insiders In The Past Month
Going ‘Small’ Could Help This New Biotech ETF Deliver Big Gains
“A biotech ETF coming to market in the midst of a global pandemic could prove to be a case of good timing for multiple reasons,”… Read More »Going ‘Small’ Could Help This New Biotech ETF Deliver Big Gains
What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
Why might investors looking to get in on the next big biotech trend want to consider picking up shares of the company highlighted in today’s… Read More »What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
Which Of These Biotech Penny Stocks Are Worth The Under-$4 Price Of Admission?
The four penny stocks highlighted in today’s article are all biopharmaceutical/biotech companies, they can all be bought for under $4, and they all have important… Read More »Which Of These Biotech Penny Stocks Are Worth The Under-$4 Price Of Admission?